Trial intelligence / Profile preview

Antibiotic Prophylaxis in Lower Third Molar Extraction

NCT07894016Phase 4Recruiting

Sponsor
Dow University of Health Sciences
Start
Oct 2026
Primary completion
Dec 2026
Countries
1
01

Overview

A Phase 4 trial of amoxicillin, clindamycin, azithromycin in surgical site infection (SSI), alveolar osteitis (AO), sponsored by Dow University of Health Sciences. Started Oct 2026; status: recruiting.

02

Drugs

amoxicillinclindamycinazithromycin
03

Conditions

surgical site infection (SSI)alveolar osteitis (AO)

Beyond the preview

Go deeper on NCT07894016.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07894016.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call